methylprednisolone hemisuccinate has been researched along with gadolinium in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dastidar, P; Elovaara, I; Lehtimäki, T; Leppäkynnäs, M; Luomala, M; Peltola, J; Ukkonen, M | 1 |
1 trial(s) available for methylprednisolone hemisuccinate and gadolinium
| Article | Year |
|---|---|
Adhesion molecules in multiple sclerosis: relation to subtypes of disease and methylprednisolone therapy.
Topics: Adult; Atrophy; Brain; Cell Adhesion Molecules; E-Selectin; Enzyme-Linked Immunosorbent Assay; Female; Gadolinium; Humans; Immunohistochemistry; Inflammation; Injections, Intravenous; Integrin alpha4beta1; Integrins; Intercellular Adhesion Molecule-1; Lymphocyte Function-Associated Antigen-1; Lymphocytes; Magnetic Resonance Imaging; Male; Methylprednisolone Hemisuccinate; Middle Aged; Monocytes; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Predictive Value of Tests; Receptors, Lymphocyte Homing; Vascular Cell Adhesion Molecule-1 | 2000 |